...
syrs-img

Syros Pharmaceuticals Inc, Common Stock

SYRS

NSQ

$0.2675

+$0.02

(7.97%)

1D
Industry: Biotechnology Sector: Health Care

Analyst Forecast

Price Chart

Key Metrics

Market Cap info-icon
This is a company’s total value as determined by the stock market. It is calculated by multiplying the total number of a company's outstanding shares by the current market price of one share.
$6.73M
P/E Ratio info-icon
This is the ratio of a security’s current share price to its earnings per share. This ratio determines the relative value of a company’s share.
0
Volume info-icon
This is the total number of shares traded during the most recent trading day.
0
Avg Volume info-icon
This is the average number of shares traded during the most recent 30 days.
0
Dividend Yield info-icon
This ratio shows how much income you earn in dividend payouts per year for every dollar invested in the stock (or the stock’s annual dividend payment expressed as a percentage of its current price).
0.00%
Beta info-icon
This measures the expected move in a stock’s price relative to movements in the overall market. The market, such as the S&P 500 Index, has a beta of 1.0. If a stock has a Beta greater (or lower) than 1.0, it suggests that the stock is more (or less) volatile than the broader market.
1.59
52-week Range info-icon
This shows the range of the stock’s price between the 52-week high (the highest price of the stock for the past 52 weeks) and the 52-week low (the lowest price of the stock for the past 52 weeks).
$0.18 L
$8.17 H
$0.2675

About Syros Pharmaceuticals Inc, Common Stock

Syros Pharmaceuticals, Inc., a biopharmaceutical company, focuses on the development of treatment for hematologic malignancies. The company's lead product candidates are Tamibarotene, a selective retinoic acid receptor alpha agonist, which is in Phase III clinical trial for genomically defined subset of patients with myelodysplastic syndrome and Phase II clinical trial for patients with acute myeloid leukemia; SY-2101, a novel oral form of arsenic trioxide for treating patients with acute promyelocytic leukemia; and SY-5609, a cyclin-dependent kinase 7 inhibitor, which is in a Phase I clinical trial in patients with select advanced solid tumors. The company was formerly known as LS22, Inc. and changed its name to Syros Pharmaceuticals, Inc. in August 2012. Syros Pharmaceuticals, Inc. was incorporated in 2011 and is headquartered in Cambridge, Massachusetts. more

Industry: BiotechnologySector: Health Care

Returns

Time FrameSYRSSectorS&P500
1-Week Return-7.76%2.3%1.73%
1-Month Return-87.32%-1.77%3.44%
3-Month Return-82.96%-6.07%7.02%
6-Month Return-94.65%2.45%13.38%
1-Year Return-89.87%12.17%32.25%
3-Year Return-99.33%10.46%29.27%
5-Year Return-99.45%46.4%90.61%
10-Year Return-99.85%109.98%190.64%

Financials

Dec '19Dec '20Dec '21Dec '22Dec '235YR TREND
Total Revenue1.98M15.09M23.49M14.88M9.94M[{"date":"2019-12-31","value":8.44,"profit":true},{"date":"2020-12-31","value":64.26,"profit":true},{"date":"2021-12-31","value":100,"profit":true},{"date":"2022-12-31","value":63.35,"profit":true},{"date":"2023-12-31","value":42.3,"profit":true}]
Cost of Revenue---2.97M2.25M[{"date":"2019-12-31","value":"-","profit":true},{"date":"2020-12-31","value":"-","profit":true},{"date":"2021-12-31","value":"-","profit":true},{"date":"2022-12-31","value":100,"profit":true},{"date":"2023-12-31","value":75.9,"profit":true}]
Gross Profit1.98M15.09M23.49M11.91M7.68M[{"date":"2019-12-31","value":8.44,"profit":true},{"date":"2020-12-31","value":64.26,"profit":true},{"date":"2021-12-31","value":100,"profit":true},{"date":"2022-12-31","value":50.72,"profit":true},{"date":"2023-12-31","value":32.71,"profit":true}]
Gross Margin100.00%100.00%100.00%80.06%77.33%[{"date":"2019-12-31","value":100,"profit":true},{"date":"2020-12-31","value":100,"profit":true},{"date":"2021-12-31","value":100,"profit":true},{"date":"2022-12-31","value":80.06,"profit":true},{"date":"2023-12-31","value":77.33,"profit":true}]
Operating Expenses79.72M97.39M122.91M141.24M138.92M[{"date":"2019-12-31","value":56.44,"profit":true},{"date":"2020-12-31","value":68.95,"profit":true},{"date":"2021-12-31","value":87.02,"profit":true},{"date":"2022-12-31","value":100,"profit":true},{"date":"2023-12-31","value":98.36,"profit":true}]
Operating Income(77.74M)(82.30M)(99.42M)(135.87M)(128.99M)[{"date":"2019-12-31","value":-7774100000,"profit":false},{"date":"2020-12-31","value":-8229700000,"profit":false},{"date":"2021-12-31","value":-9942000000,"profit":false},{"date":"2022-12-31","value":-13587300000,"profit":false},{"date":"2023-12-31","value":-12898800000,"profit":false}]
Total Non-Operating Income/Expense-(3.11M)9.04M39.22M(33.90M)[{"date":"2019-12-31","value":"-","profit":true},{"date":"2020-12-31","value":-7.92,"profit":false},{"date":"2021-12-31","value":23.06,"profit":true},{"date":"2022-12-31","value":100,"profit":true},{"date":"2023-12-31","value":-86.43,"profit":false}]
Pre-Tax Income(75.44M)(84.04M)(86.56M)(94.65M)(164.57M)[{"date":"2019-12-31","value":-7543800000,"profit":false},{"date":"2020-12-31","value":-8403800000,"profit":false},{"date":"2021-12-31","value":-8655800000,"profit":false},{"date":"2022-12-31","value":-9465400000,"profit":false},{"date":"2023-12-31","value":-16457400000,"profit":false}]
Income Taxes(2.30M)1.79M3.91M(45.35M)2.08M[{"date":"2019-12-31","value":-58.95,"profit":false},{"date":"2020-12-31","value":45.87,"profit":true},{"date":"2021-12-31","value":100,"profit":true},{"date":"2022-12-31","value":-1160.81,"profit":false},{"date":"2023-12-31","value":53.34,"profit":true}]
Income After Taxes-(85.83M)(90.47M)(49.30M)(166.66M)[{"date":"2019-12-31","value":"-","profit":true},{"date":"2020-12-31","value":-8583000000,"profit":false},{"date":"2021-12-31","value":-9046500000,"profit":false},{"date":"2022-12-31","value":-4930100000,"profit":false},{"date":"2023-12-31","value":-16665810500,"profit":false}]
Income From Continuous Operations(75.44M)(84.04M)(86.56M)(94.65M)(164.57M)[{"date":"2019-12-31","value":-7543800000,"profit":false},{"date":"2020-12-31","value":-8403800000,"profit":false},{"date":"2021-12-31","value":-8655800000,"profit":false},{"date":"2022-12-31","value":-9465400000,"profit":false},{"date":"2023-12-31","value":-16457400000,"profit":false}]
Income From Discontinued Operations-----[{"date":"2019-12-31","value":"-","profit":true},{"date":"2020-12-31","value":"-","profit":true},{"date":"2021-12-31","value":"-","profit":true},{"date":"2022-12-31","value":"-","profit":true},{"date":"2023-12-31","value":"-","profit":true}]
Net Income(75.44M)(85.83M)(90.47M)(49.30M)(164.57M)[{"date":"2019-12-31","value":-7543800000,"profit":false},{"date":"2020-12-31","value":-8583000000,"profit":false},{"date":"2021-12-31","value":-9046500000,"profit":false},{"date":"2022-12-31","value":-4930100000,"profit":false},{"date":"2023-12-31","value":-16457400000,"profit":false}]
EPS (Diluted)(18.90)(18.20)(13.80)(12.78)(5.76)[{"date":"2019-12-31","value":-1890,"profit":false},{"date":"2020-12-31","value":-1820,"profit":false},{"date":"2021-12-31","value":-1380,"profit":false},{"date":"2022-12-31","value":-1278,"profit":false},{"date":"2023-12-31","value":-576,"profit":false}]

Ratios

Liquidity

These ratios help you determine the liquidity of the company. Higher is better.

SYRS
Cash Ratio 2.05
Current Ratio 2.25

Asset Efficiency

These ratios help you understand the company's efficiency in using its assets to generate returns. Higher is better. For ROE, average long term is around 14%, less than 10% is poor.

SYRS
ROA (LTM) -59.88%
ROE (LTM) -776.96%

Liabilities

These ratios help you understand the company's liabilities, gauging the riskiness of the investment.

SYRS
Debt Ratio Lower is generally better. Negative is bad. 1.13
Common Equity/Total Assets Higher is better. Lower can suggest investment is riskier. -0.13

Valuation

These ratios help you understand the company's valuation. Lower may indicate cheaper stocks.

SYRS
Trailing PE NM
Forward PE NM
P/S (TTM) 17.44
P/B 10.65
Price/FCF NM
EV/R 22.50
EV/Ebitda NM
PEG NM

FAQs

What is Syros Pharmaceuticals Inc share price today?

Syros Pharmaceuticals Inc (SYRS) share price today is $0.2675

Can Indians buy Syros Pharmaceuticals Inc shares?

Yes, Indians can buy shares of Syros Pharmaceuticals Inc (SYRS) on Vested. To buy Syros Pharmaceuticals Inc from India, you can open a US Brokerage account on Vested today by clicking on Sign Up or Invest in SYRS stock at the top of this page. The account opening process is completely digital and secure, and takes a few minutes to complete.

Can Fractional shares of Syros Pharmaceuticals Inc be purchased?

Yes, you can purchase fractional shares of Syros Pharmaceuticals Inc (SYRS) via the Vested app. You can start investing in Syros Pharmaceuticals Inc (SYRS) with a minimum investment of $1.

How to invest in Syros Pharmaceuticals Inc shares from India?

You can invest in shares of Syros Pharmaceuticals Inc (SYRS) via Vested in three simple steps:

  • Click on Sign Up or Invest in SYRS stock at the top of this page
  • Breeze through our fully digital and secure KYC process and open your US Brokerage account in a few minutes
  • Transfer USD funds to your US Brokerage account and start investing in Syros Pharmaceuticals Inc shares
What is Syros Pharmaceuticals Inc 52-week high and low stock price?

The 52-week high price of Syros Pharmaceuticals Inc (SYRS) is $8.17. The 52-week low price of Syros Pharmaceuticals Inc (SYRS) is $0.18.

What is Syros Pharmaceuticals Inc price-to-earnings (P/E) ratio?

The price-to-earnings (P/E) ratio of Syros Pharmaceuticals Inc (SYRS) is

What is Syros Pharmaceuticals Inc price-to-book (P/B) ratio?

The price-to-book (P/B) ratio of Syros Pharmaceuticals Inc (SYRS) is 10.65

What is Syros Pharmaceuticals Inc dividend yield?

The dividend yield of Syros Pharmaceuticals Inc (SYRS) is 0.00%

What is the Market Cap of Syros Pharmaceuticals Inc?

The market capitalization of Syros Pharmaceuticals Inc (SYRS) is $6.73M

What is Syros Pharmaceuticals Inc’s stock symbol?

The stock symbol (or ticker) of Syros Pharmaceuticals Inc is SYRS

Signup to access all features and start your US investing journey!

  • Open your account in minutes
  • Take your portfolio global, starting at just $1
Get started

Add ticker to compare

Scroll to Top